Application

15475227 · IMMUNOMODULATORS

Filed 2017-03-31 · Granted · Patent 10358463 (2019-07-23) The official file ↗The patent and its PDF ↗ · Art unit 1654 · Examiner Fred H Reynolds Typical · CPC C07K 7/08 · Bristol-Myers Squibb Company · Sterne, Kessler, Goldstein & Fox P.L.L.C.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

8.0 mo

to disposition 27.7 mo

Statutes raised

102 103 112 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.